Hartford, Conn.-based Aetna will auction a portfolio of its Medicare Advantage assets in hopes of soothing antitrust concerns over its pending merger with Louisville, Ky.-based Humana, Reuters reported.
The auction comes as the insurer requests antitrust approval for its $37 billion acquisition of Humana. If approved, Aetna and Humana’s combined Medicare Advantage business would be the US’s largest manager of health insurance for seniors and the disabled. Aetna hopes the sale will assuage antitrust concerns, Reuters reported.
The insurer will start collecting bids next week, and already sent out pitchbooks to possible buyers. The sale may take several months, and its effect on antitrust approval is uncertain. The assets are expected to be valued around $1 billion, according to the report.
Full Content: Health Care Dive
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI